Nepafenac Patent Expiration
Nepafenac is Used for treating ocular inflammation. It was first introduced by Harrow Eye Llc
Nepafenac Patents
Given below is the list of patents protecting Nepafenac, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Ilevro | US8921337 | Carboxyvinyl polymer-containing nanoparticle suspensions | Mar 31, 2032 | Harrow Eye |
| Ilevro | US9662398 | Carboxylvinyl polymer-containing nanoparticle suspensions | Dec 01, 2030 | Harrow Eye |
| Nevanac | US7834059 | Topical nepafenac formulations | Jan 31, 2027 | Harrow Eye |
| Nevanac | US8071648 | Topical nepafenac formulations | Dec 02, 2025 | Harrow Eye |
| Nevanac | US8324281 | Topical nepafenac formulations | Dec 02, 2025 | Harrow Eye |
| Ilevro | US7947295 | Ophthalmic compositions containing a synergistic combination of two polymers |
Jun 08, 2024
(Expired) | Harrow Eye |
| Ilevro | US6403609 | Ophthalmic compositions containing galactomannan polymers and borate |
Jul 17, 2018
(Expired) | Harrow Eye |
| Ilevro | US5475034 | Topically administrable compositions containing 3-benzoylphenylacetic acid derivatives for treatment of ophthalmic inflammatory disorders |
Jun 06, 2014
(Expired) | Harrow Eye |
| Nevanac | US5475034 | Topically administrable compositions containing 3-benzoylphenylacetic acid derivatives for treatment of ophthalmic inflammatory disorders |
Jun 06, 2014
(Expired) | Harrow Eye |
Nepafenac's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List